![]() |
市场调查报告书
商品编码
1378843
细胞计数市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测Cell Counting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球细胞计数市场规模达到104亿美元。展望未来, IMARC Group预计到2028年市场规模将达到155亿美元,2022-2028年复合年增长率(CAGR)为6.9%。
细胞计数是指用于分析通常悬浮在血液或其他体液中的细胞或胶束的技术。用于细胞计数的一些常见仪器包括血球计数器、分光光度计、流式细胞仪、自动细胞计数器等。细胞计数有助于对细胞类型进行分类并透过探针检测疾病,从而为患者制定最佳治疗计划。它还有助于了解细胞的结构和组成,用于染色体分析、蛋白质表现、癌症诊断、血液恶性肿瘤等。因此,细胞计数广泛应用于医院、诊断实验室、研究和学术机构、製药和生物技术公司等
癌症、爱滋病毒/爱滋病、白血病、阿兹海默症等各种慢性疾病的盛行率不断上升,推动了对细胞计数技术的需求。此外,分子生物学、免疫学、病理学等不同医学领域也越来越多地采用细胞计数仪器来开发下一代疗法,这也促进了市场的成长。除此之外,越来越多地利用细胞计数来识别和测定原发性肿瘤、循环肿瘤和转移性肿瘤,进一步推动了市场的成长。此外,干细胞疗法的广泛采用也推动了全球对各种细胞计数仪器的需求。与此一致的是,人们对细胞计数技术在免疫表型、细胞分选、细胞增殖测定和细胞内钙通量方面的众多优势的认识不断提高,这进一步推动了市场的成长。此外,多个政府机构对生物技术、肿瘤干细胞治疗等领域广泛研发活动的投资不断增加,也促进了细胞计数技术的采用。未来几年,自动化产品变体的推出将继续推动全球细胞计数市场的发展,这些产品具有以更高的速度处理更大样本量的能力。
The global cell counting market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2022-2028.
Cell counting refers to a technique used for the analysis of the cells or micelles that are usually suspended in blood or other body fluids. Some of the common instruments used for cell counting includes hemocytometers, spectrophotometers, flow cytometers, automated cell counters, etc. Cell counting aids in classifying cell types and detecting disease through probes to develop the best treatment plan for the patient. It also helps in understanding the structure and composition of the cells for chromosome analysis, protein expression, cancer diagnosis, hematological malignancies, etc. As a result, cell counting is extensively used across hospitals, diagnostic laboratories, research and academic institutes, pharmaceutical and biotechnology companies, etc.
The rising prevalence of various chronic ailments, such as cancer, HIV-AIDS, leukemia, Alzheimer's, etc., is propelling the demand for cell counting techniques. Moreover, the growing adoption of cell counting instruments across diverse medical fields, such as molecular biology, immunology, pathology, etc., for developing next-generation therapeutics is also augmenting the market growth. In addition to this, the increasing utilization of cell counting for the identification and determination of primary tumor, circulating tumor, and metastatic tumor is further bolstering the market growth. Additionally, the widespread adoption of stem cell therapy is also propelling the demand for various cell counting instruments on a global level. In line with this, the rising awareness towards numerous benefits of cell counting technique in immunophenotyping, cell sorting, cell proliferation assays and intracellular calcium flux is further driving the market growth. Moreover, the increasing investments by several government bodies in extensive R&D activities pertaining to the fields of biotechnology, oncology stem cell therapeutics, etc., are also bolstering the adoption of cell counting techniques. In the coming years, the introduction of automated product variants with enhanced ability to process larger sample sizes at a higher speed will continue to drive the global market for cell counting.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell counting market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and end user.
Consumables
Reagents
Assay Kits
Microplates
Accessories
Instruments
Spectrophotometers
Flow Cytometers
Hematology Analyzers
Cell Counters
Hospitals and Diagnostic Laboratories
Research and Academic Institutes
Pharmaceutical and Biotechnology Companies
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd. (Roche Holding AG)., Merck & Co. Inc., PerkinElmer Inc. and Thermo Fisher Scientific Inc.